22 enero 2015
Upending decades-old dogma, a team of scientists say enzymes long categorized as promoting cancer are, in fact, tumor suppressors and that current clinical efforts to develop inhibitor-based drugs should instead focus on restoring the enzymes’ activities.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/A11ycpG7Boo/150122132736.htm
